Parametric Portfolio Associates’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$5.41M Sell
277,250
-90,482
-25% -$1.37M ﹤0.01% 1797
2021
Q4
$6M Buy
367,732
+98,664
+37% +$1.64M ﹤0.01% 1732
2021
Q3
$7.5M Buy
269,068
+667
+0.2% +$19K ﹤0.01% 1547
2021
Q2
$7.96M Buy
268,401
+7,748
+3% +$223K ﹤0.01% 1549
2021
Q1
$7.29M Buy
260,653
+959
+0.4% +$26.5K ﹤0.01% 1903
2020
Q4
$7.36M Sell
259,694
-36,497
-12% -$945K ﹤0.01% 1813
2020
Q3
$7.45M Buy
296,191
+42,801
+17% +$1.12M 0.01% 1593
2020
Q2
$6.19M Sell
253,390
-16,189
-6% -$320K ﹤0.01% 1729
2020
Q1
$3.99M Sell
269,579
-67,150
-20% -$1.39M ﹤0.01% 1903
2019
Q4
$5.46M Buy
336,729
+81,921
+32% +$1.27M ﹤0.01% 2005
2019
Q3
$3.31M Buy
254,808
+143,593
+129% +$1.76M ﹤0.01% 2321
2019
Q2
$1.44M Buy
111,215
+53,810
+94% +$678K ﹤0.01% 2856
2019
Q1
$905K Buy
57,405
+4,787
+9% +$83K ﹤0.01% 3080
2018
Q4
$1.06M Buy
52,618
+5,784
+12% +$127K ﹤0.01% 2948
2018
Q3
$1.16M Buy
46,834
+9,429
+25% +$256K ﹤0.01% 3010
2018
Q2
$1.03M Sell
37,405
-35,444
-49% -$1.07M ﹤0.01% 3042
2018
Q1
$2.24M Sell
72,849
-6
-0% -$193 ﹤0.01% 2539
2017
Q4
$2.6M Buy
72,855
+37,808
+108% +$1.09M ﹤0.01% 2423
2017
Q3
$966K Buy
35,047
+5,935
+20% +$144K ﹤0.01% 3069
2017
Q2
$769K Buy
29,112
+1,711
+6% +$38.2K ﹤0.01% 3127
2017
Q1
$570K Buy
27,401
+1,524
+6% +$31.3K ﹤0.01% 3137
2016
Q4
$536K Buy
25,877
+5,040
+24% +$84.4K ﹤0.01% 3152
2016
Q3
$338K Sell
20,837
-231
-1% -$3.35K ﹤0.01% 3364
2016
Q2
$287K Sell
21,068
-1,856
-8% -$32.8K ﹤0.01% 3468
2016
Q1
$400K Buy
+22,924
New +$467K ﹤0.01% 3447

Other funds holding RVNC